WuXi AppTec Co Ltd
SSE:603259

Watchlist Manager
WuXi AppTec Co Ltd Logo
WuXi AppTec Co Ltd
SSE:603259
Watchlist
Price: 49.63 CNY -5.59% Market Closed
Market Cap: 124.1B CNY
Have any thoughts about
WuXi AppTec Co Ltd?
Write Note

Operating Margin
WuXi AppTec Co Ltd

27.4%
Current
24%
Average
2.4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
27.4%
=
Operating Profit
10.6B
/
Revenue
38.7B

Operating Margin Across Competitors

Country CN
Market Cap 124.1B CNY
Operating Margin
27%
Country US
Market Cap 1.3T USD
Operating Margin
14%
Country US
Market Cap 196.3B USD
Operating Margin
17%
Country US
Market Cap 170.3B USD
Operating Margin
21%
Country KR
Market Cap 66.5T KRW
Operating Margin
31%
Country CH
Market Cap 37.6B CHF
Operating Margin
13%
Country US
Market Cap 38.5B USD
Operating Margin
25%
Country US
Market Cap 36.7B USD
Operating Margin
14%
Country US
Market Cap 26.4B USD
Operating Margin
28%
Country US
Market Cap 23B USD
Operating Margin
20%
Country US
Market Cap 22.3B USD
Operating Margin
8%
No Stocks Found

WuXi AppTec Co Ltd
Glance View

Market Cap
124.1B CNY
Industry
Life Sciences Tools & Services

WuXi AppTec Co., Ltd. is a prominent global healthcare platform that plays a pivotal role in empowering the pharmaceutical, biotechnology, and medical device industries. Founded in 2000 and headquartered in Shanghai, WuXi has cultivated a reputation for excellence through its extensive suite of services, which span the entire drug development lifecycle. From drug discovery to manufacturing, the company leverages cutting-edge technologies and a rich network of expertise to facilitate the development of innovative therapeutics. This comprehensive capability enables WuXi to serve as a trusted partner for clients, helping to streamline the complex path from concept to commercialization. With a focus on innovation and quality, WuXi AppTec has distinguished itself in the competitive landscape of contract research organizations (CROs) and contract manufacturing organizations (CMOs). The company's robust growth trajectory is underpinned by strategic investments in technology and infrastructure, as well as a commitment to expanding its global footprint. WuXi's expansive service offerings not only enhance operational efficiency for its partners but also align with the increasing demand for faster and more cost-effective drug development solutions. For investors, WuXi signifies an opportunity to engage with a market leader poised to capitalize on the burgeoning biopharmaceutical sector, driven by rising global healthcare needs and transformative advancements in science and technology.

Intrinsic Value
88.5 CNY
Undervaluation 44%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
27.4%
=
Operating Profit
10.6B
/
Revenue
38.7B
What is the Operating Margin of WuXi AppTec Co Ltd?

Based on WuXi AppTec Co Ltd's most recent financial statements, the company has Operating Margin of 27.4%.